| | | |  | | | | By Andrew Joseph Caitlin O'Hara for STAT Under new rules, clinics giving methadone for opioid addiction don't have to require daily visits. But some resist the flexibility. Read More | | By Damian Garde Adobe The latest Alzheimer's disease treatment from Eisai and Biogen needs to be cheaper than $20,000 a year to be cost-effective, ICER says. Read More | | By Ambar Castillo Jae C. Hong/AP Deaths from Covid-19 and drug overdoses drove U.S. life expectancy to fall to 76.4 years in 2021, the lowest level since 1996. Read More | | Sponsored Insight by Sanofi Small changes have a large impact, but there is more to do for those living with multiple myeloma Efforts to double down on next generation approaches to treating multiple myeloma have contributed to durable survival gains. Oncologists have played a key role by embracing increasingly sophisticated data-driven approaches, including the exploration of artificial intelligence tools and predictive analytics to help inform treatment decisions based on individual patient variables. Read more about the latest in the multiple myeloma space in our Q&A with Sanofi's Global Head of Oncology Development & Pediatric Innovation, Peter Adamson. | | By Theresa Gaffney Adobe Vanna Health, co-founded by Thomas Insel, has quietly raised $29 million to support patients with serious mental illness. Read More | | By Rachel Cohrs BRENDAN SMIALOWSKI/AFP via Getty Images Congress wants to give pandemic response a permanent White House home, rather than the cast of rotating "czars." Read More | | By Richard Marfuggi and Aparna Ahuja and Rick A. Bright David Goulding/Wellcome Sepsis kills millions of people a year. Its combination with Covid-19 reinforced the need for faster diagnostics and better therapies. Read More | | By Damian Garde and Adam Feuerstein We look back on the biggest biotech stories of the past year and how the industry seems stuck in a sentiment rut. Read More | |
No comments